Creon DR 36,000 unit capsule UU 100S
Ended Awarded
- Contract number
- SPE2DR26F9BY1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,610
Award facts
- Contract value 100% obligated
- $15,609.64 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $15,609.64 to AmerisourceBergen Drug Corp for 36,000 unit capsules of Creon DR 100s on November 17, 2025, with an ultimate completion date of November 18, 2025. This non-competitive delivery order utilizes firm fixed pricing and is performed at the contractor's Conshohocken, Pennsylvania facility. The award represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to military healthcare systems worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting Defense Health Agency and military healthcare programs. The contractor's federal contract portfolio demonstrates extensive capabilities across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, and medical supplies. This specific delivery order for Creon DR—an enzyme replacement therapy used in pancreatic insufficiency treatment—exemplifies the company's role in supplying specialized pharmaceutical products to support military medical readiness and veteran healthcare needs through the DLA's medical supply chain.
Quick answers
Who was awarded contract SPE2DR26F9BY1?
SPE2DR26F9BY1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 17, 2025.
How much is contract SPE2DR26F9BY1 worth?
The government has obligated $15,610 on SPE2DR26F9BY1.
Is contract SPE2DR26F9BY1 an order under another contract?
Yes. SPE2DR26F9BY1 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9BY1 competed?
The extent of competition for SPE2DR26F9BY1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award